WHO WE ARE
Driving Innovation, Delivering U.S.-Manufactured APIs
The API Innovation Center (APIIC) is a non-profit organization dedicated to enabling the delivery of market-competitive commercial supply of U.S.-made Active Pharmaceutical Ingredients (APIs) to address critical needs in the healthcare supply chain while fostering job growth throughout the St. Louis region.
The Lomustine Project
Solving the Lomustine API Crisis for Glioblastoma Patients
The APIIC’s initial project is the U.S. production of lomustine, a chemotherapy drug used to treat glioblastoma, the most common and aggressive form of brain cancer. There is currently no U.S. source of lomustine. According to the Society for Neuro-Oncology, “the field of neuro-oncology is in the midst of a crisis with lomustine.” The APIIC is working in partnership with Continuity Pharma and the Glioblastoma Foundation to resolve the lomustine crisis utilizing the advanced technologies of continuous flow manufacturing.
News & Updates
Keep Up to Date on Our Latest
The API Innovation Center Participated in a Roundtable with EDA Assistant Secretary Castillo and Other St. Louis Leaders to Discuss the $25 Million Grant for Advanced Manufacturing
On October 19th, U.S. Economic Development Administration (EDA) Assistant Secretary Alejandra...
Get In Touch
Contact Us Today
4240 Duncan Ave., Suite 200
St. Louis, MO 63110